Part of the CoreAge Rx promotional publishing network. Read the disclosure.

Original documents

Read what each source actually establishes.

Product pages describe an offer or formulation. Posted labels identify a documented version. Regulatory and professional sources explain their own context. These groups organize the records without giving them a clinical score.

Public product records

Provider product page · Accessed 2026-09-27

CoreAge Rx Pore Favor product description

Read the original document

Articles using this record

Provider offer page · Accessed 2026-09-27

CoreAge Rx Pore Favor current offer

Read the original document

Articles using this record

Manufacturer product and acne-treatment labeling · Accessed 2026-09-27

The Ordinary Salicylic Acid 2% Solution: current US product

Read the original document

Articles using this record

Manufacturer product page · Accessed 2026-09-27

CeraVe Acne Control Cleanser: exact US product

Read the original document

Articles using this record

Official labeling record; revised March 2025 · Accessed 2026-09-27

CeraVe Acne Control Cleanser: L’Oreal Drug Facts record

Read the original document

Articles using this record

Regulatory and clinical context

Regulator explanation · Accessed 2026-09-27

FDA: compounding questions and answers

Read the original document

Articles using this record

Medical society patient guidance · Accessed 2026-09-27

American Academy of Dermatology: moisturizer and acne treatment

Read the original document

Articles using this record

Regulator consumer labeling guidance · Accessed 2026-09-27

FDA: reading an OTC Drug Facts label

Read the original document

Articles using this record

Medical society patient guidance; updated January 10, 2023 · Accessed 2026-09-27

American Academy of Dermatology: adult acne treatment

Read the original document

Articles using this record

Current regulator framework; not a product-specific compliance finding · Accessed 2026-09-27

FDA: OTC drug monograph review process

Read the original document

Articles using this record

Regulator explanation of listing versus approval · Accessed 2026-09-27

FDA: National Drug Code Directory limitations

Read the original document

Articles using this record